Biochar as a Soil Amendment: A Review of the Environmental Implications

The term 'biochar' refers to black carbon formed by the pyrolysis of biomass i.e. by heating biomass in an oxygen-free or low oxygen environment such that it does not (or only partially) combusts. Traditional charcoal is one example of biochar produced from wood. The term 'biochar' is much broader than this however, encompassing black carbon produced from any biomass feedstock. The use of biochar as a soil additive has been proposed as a means to simultaneously mitigate anthropogenic climate change whilst improving agricultural soil fertility. This paper provides a review of what is known about both of these claims and also about the wider environmental implications of the adoption of this process. The intention of this review is not just to summarise current knowledge of the subject, but also to identify gaps in knowledge that require further research

Guide to Developing Agriculture, Forestry and Other Land-Use (AFOLU) Carbon Market Projects under Ethiopia’s Productive Safety Net Programme (PSNP)

This report outlines the general steps required for development of a carbon project intended for sale of carbon credits via a carbon offset program, whether compliance or voluntary. While there are differences among the numerous offset programs, the major components are generally the same and any carbon project originating in the agriculture, forestry and other land use (AFOLU) sector will follow these steps. This report was written as a guide to development of carbon projects for Ethiopia’s Productive Safety Net Programme (PSNP), but the same process outlined here is equally applicable to any AFOLU carbon project.This work was supported by the PSNP Climate Smart Initiative. The PSNP is implemented by the Government of Ethiopia with support from the following development partners: Canadian International Development Agency, Irish Aid, European Commission, Royal Netherlands Embassy, Swedish International Development Cooperation Agency, UK Department for International Development, United States Agency for International Development, World Food Program and World Bank

Ethiopia’s Productive Safety Net Program (PSNP): Soil carbon and fertility impact assessment

Ethiopia’s climate smart initiative (CSI) aims to integrate the implications of climate change into the Productive Safety Net Program (PSNP) activities, and systems to strengthen this important social safety net program, and enable Ethiopia to better manage climate risks and help its chronically food insecure population to better cope with shocks, create assets and secure livelihoods, even as the climate changes. CSI is also tasked with preparing the ground for PSNP’s sustainable public work programs to access climate finance and possibly payments from ecosystem services and benefits to spur and enable the transition towards low-carbon, climate-resilient growth and development. More robust and cost effective analysis and information on soil carbon stock changes and associate soil fertility and productivity indicators over space and time is required at multiple stages of development and implementation of PSNP’ participatory integrated watershed management projects to access climate finance. The main objectives of this study are to: (i) assemble business as usual and project scenario baseline database on soil carbon and other soils fertility, health and productivity indicators for six chronically food insecure and vulnerable Ethiopian regional states (i.e., Afar, Amhara, Oromia, SNNPR, Somali and Tigray), where PSNP’s sustainable agricultural and environmental rehabilitation public works have been implemented widely, ii) assess the impacts of Ethiopia’s PSNP participatory integrated watershed intervention projects on soil carbon capture and sequestration, as well as on other climate smart environmental and agricultural co-benefits in light of climate change, food security and low-carbon livelihoods in these regions, and (iii) support Ethiopia’s safety net climate smart initiative to take advantage of international carbon and climate finance opportunities to support sustaining the existing activities as well as scaling-up future implementations of PSNP participatory watershed public works projects in Ethiopia.This work was supported by the PSNP Climate Smart Initiative. The PSNP is implemented by the Government of Ethiopia with support from the following development partners: Canadian International Development Agency, Irish Aid, European Commission, Royal Netherlands Embassy, Swedish International Development Cooperation Agency, UK Department for International Development, United States Agency for International Development, World Food Program and World Bank

An open-source biomass pyrolysis reactor

Despite its long history of technological development, much charcoal production still relies on polluting and inefficient technologies utilizing traditional kiln designs. In addition to the need for improved charcoal production systems, the growing interest globally in pyrolysis of biomass to generate biochar as a soil fertility improver and for climate change mitigation may drive an increasing demand for such technologies. Accordingly, there is a clear need in developing countries for access to safe, affordable, and efficient open‐source designs and technology that can be fabricated locally. The design described here includes computational fluid dynamics modeling which demonstrated that the design exhibits a stable flow and combustion pattern. A hazard and operability (HAZOP) study, mass and energy modeling, and costing of all components and fabrication were also conducted for a prototype kiln that will accept up to 250 kg biomass h‐1. Fabrication and installation costs were estimated using actual commercial quotations based on detailed engineering drawings and design, and were found to be $580 000 for a 250 kg h‐1 unit. We therefore find that this pyrolysis system promises to be economical on a small scale. It can utilize waste lignocellulosic materials for feedstock, thus alleviating demand pressure on woodlands to provide feedstocks. It was, therefore, concluded that the pyrolysis unit described here promises to provide an affordable and efficient open‐source design that can be fabricated locally in developing countries without licensing restrictions or royalties

Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1

Primary ciliary dyskinesia (PCD) is a rare heterogenous condition that causes progressive suppurative lung disease, chronic rhinosinusitis, chronic otitis media, infertility and abnormal situs. 'Better Experimental Approaches to Treat Primary Ciliary Dyskinesia' (BEAT-PCD) is a network of scientists and clinicians coordinating research from basic science through to clinical care with the intention of developing treatments and diagnostics that lead to improved long-term outcomes for patients. BEAT-PCD activities are supported by EU funded COST Action (BM1407). The second BEAT-PCD conference, and third PCD training school were held jointly in April 2017 in Valencia, Spain. Presentations and workshops focussed on advancing the knowledge and skills relating to PCD in: basic science, epidemiology, diagnostic testing, clinical management and clinical trials. The multidisciplinary conference provided an interactive platform for exchanging ideas through a program of lectures, poster presentations, breakout sessions and workshops. Three working groups met to plan consensus statements. Progress with BEAT-PCD projects was shared and new collaborations were fostered. In this report, we summarize the meeting, highlighting developments made during the meeting

Developing Feature Types and Related Catalogues for the Marine Community - Lessons from the MOTIIVE project.

MOTIIVE (Marine Overlays on Topography for annex II Valuation and Exploitation) is a project funded as a Specific Support Action (SSA) under the European Commission Framework Programme 6 (FP6) Aeronautics and Space Programme. The project started in September 2005 and finished in October 2007. The objective of MOTIIVE was to examine the methodology and cost benefit of using non-proprietary data standards. Specifically it considered the harmonisation requirements between the INSPIRE data component ‘elevation’ (terrestrial, bathymetric and coastal) and INSPIRE marine thematic data for ‘sea regions’, ‘oceanic spatial features’ and ‘coastal zone management areas’. This was examined in context of the requirements for interoperable information systems as required to realise the objectives of GMES for ‘global services’. The work draws particular conclusions on the realisation of Feature Types (ISO 19109) and Feature Type Catalogues (ISO 19110) in this respect. More information on MOTIIVE can be found at www.motiive.net

Land-based measures to mitigate climate change : potential and feasibility by country

Acknowledgements The design of this study and the data generated was guided by expert consultations and relied on the help of many. We thank all those who contributed: Sierra Gladfelter, Jo House, Mercedes Bustamante, Susan Cook-Patton, Sara Leavitt, Nick Wolff, and Thomas Worthington. We thank M.-J. Valentino at Imaginary Office for helping to design the first three figures. This work was supported by the authors’ institutions and funding sources, including the Climate and Land-use Alliance, the Dutch Ministry of Agriculture, Nature Management and Food Quality, and the EU H2020 projects VERIFY and ENGAGE (grant agreement no. 821471).Peer reviewedPublisher PD

Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Background Musculoskeletal disorders include more than 150 different conditions affecting joints, muscles, bones, ligaments, tendons, and the spine. To capture all health loss from death and disability due to musculoskeletal disorders, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) includes a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain. This category is called other musculoskeletal disorders and includes, for example, systemic lupus erythematosus and spondylopathies. We provide updated estimates of the prevalence, mortality, and disability attributable to other musculoskeletal disorders and forecasted prevalence to 2050. Methods Prevalence of other musculoskeletal disorders was estimated in 204 countries and territories from 1990 to 2020 using data from 68 sources across 23 countries from which subtraction of cases of rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout from the total number of cases of musculoskeletal disorders was possible. Data were analysed with Bayesian meta-regression models to estimate prevalence by year, age, sex, and location. Years lived with disability (YLDs) were estimated from prevalence and disability weights. Mortality attributed to other musculoskeletal disorders was estimated using vital registration data. Prevalence was forecast to 2050 by regressing prevalence estimates from 1990 to 2020 with Socio-demographic Index as a predictor, then multiplying by population forecasts. Findings Globally, 494 million (95% uncertainty interval 431–564) people had other musculoskeletal disorders in 2020, an increase of 123·4% (116·9–129·3) in total cases from 221 million (192–253) in 1990. Cases of other musculoskeletal disorders are projected to increase by 115% (107–124) from 2020 to 2050, to an estimated 1060 million (95% UI 964–1170) prevalent cases in 2050; most regions were projected to have at least a 50% increase in cases between 2020 and 2050. The global age-standardised prevalence of other musculoskeletal disorders was 47·4% (44·9–49·4) higher in females than in males and increased with age to a peak at 65–69 years in male and female sexes. In 2020, other musculoskeletal disorders was the sixth ranked cause of YLDs globally (42·7 million [29·4–60·0]) and was associated with 83 100 deaths (73 600–91 600). Interpretation Other musculoskeletal disorders were responsible for a large number of global YLDs in 2020. Until individual conditions and risk factors are more explicitly quantified, policy responses to this burden remain a challenge. Temporal trends and geographical differences in estimates of non-fatal disease burden should not be overinterpreted as they are based on sparse, low-quality data.publishedVersio

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. Methods: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. Findings: Global DALYs increased from 2·63 billion (95% UI 2·44–2·85) in 2010 to 2·88 billion (2·64–3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7–17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8–6·3) in 2020 and 7·2% (4·7–10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0–234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7–198·3]), neonatal disorders (186·3 million [162·3–214·9]), and stroke (160·4 million [148·0–171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0–19·8]), depressive disorders (16·4% [11·9–21·3]), and diabetes (14·0% [10·0–17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7–27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6–63·6) in 2010 to 62·2 years (59·4–64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6–2·9) between 2019 and 2021. Interpretation: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. Funding: Bill & Melinda Gates Foundation

Climate finance and carbon markets for Ethiopia’s Productive Safety Net Programme (PSNP): Executive Summary for Policymakers.

Ethiopia’s Productive Safety Net Programme (PSNP) is recognized as a model public works safety net program, which provides food and cash payments to households suffering from food insecurity in return for labor that builds public infrastructure. In addition to the target benefits of food security and infrastructure development, PSNP’s participatory water-shed management interventions, while not their primary objective, are already delivering climate-change mitigation benefits by sequestering carbon in soils and biomass and reducing emissions of greenhouse gases (GHGs) from the agricultural, forestry and other land use (AFOLU) sector. New opportunities for support from dedicated climate finance channels could be opened up by quantifying the climate change mitigation benefits (a.k.a. carbon benefits) generated by PSNP activities. This report summarizes the potential of PSNP's food security program to contribute to climate change mitigation, and the policy actions required to access international climate finance to support this program.This work was supported by the PSNP Climate Smart Initiative. The PSNP is implemented by the Government of Ethiopia with support from the following development partners: Canadian International Development Agency, Irish Aid, European Commission, Royal Netherlands Embassy, Swedish International Development Cooperation Agency, UK Department for International Development, United States Agency for International Development, World Food Program and World Bank